Whalegun
Home

Mittie Doyle, Chief Medical Officer: Avalo Therapeutics AVTX Sell · Filed 06/01

Trade details

Type
Insider sale
Amount
$10,864
Shares · price
679 sh · $16.00 a share
Held after
47,122 sh
Stock
Avalo Therapeutics AVTX
Person
Mittie DoyleChief Medical Officer
Trade date
26/05/28
Filed
26/06/01
Days to filing
4 days

Sold 1.4% of holdings

Share of holding sold
1.4%

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 04/28~06/27

Mittie Doyle's recent trades

  • Mittie Doyle

    Planned sale10b5-1 planAvalo Therapeutics

    $98.7K

    Filed 08/17

  • Mittie Doyle

    Planned sale10b5-1 planAvalo Therapeutics

    $12.4K

    Filed 08/10

  • Mittie Doyle

    Sell10b5-1 planAvalo Therapeutics

    $26.1K

    Filed 06/25

  • Mittie Doyle

    Sell10b5-1 planAvalo Therapeutics

    $56.3K

    Filed 05/19

  • Mittie Doyle

    Sell10b5-1 planAvalo Therapeutics

    $952.8K

    Filed 05/07

Mittie Doyle, Chief Officer — sold $10.9K of Avalo Therapeutics AVTX · 1.4% of holdings · 10b5-1 plan | Whalegun